Hydrocortisone 1% ointment 10g

$16.00

Hydrocortisone 1% ointment 10 g

Lucocorticoid, anti-inflammatory, anti-allergic, antipruritic and anti-exudative

Free Shipping

Description

Hydrocortisone 1% ointment 10 g

Composition:
active substance hydrocortisone: hydrocortisone acetate; 1 g of ointment contains hydrocortisone acetate 10 mg hydrocortisone excipients: white soft paraffin, methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), lanolin, pentol, purified water, stearic acid.
Pharmacological group:
Corticosteroids for dermatological use. ATX code D07A A02.
Indications:
Superficial uninfected dermatoses, which are treated with local corticosteroids (eczema, allergic and contact dermatitis, neurodermatitis, psoriasis). Continuation of treatment or maintenance therapy for dermatoses for which strong corticosteroids have been used in the past.
Contraindications:
Skin lesions caused by bacterial infections (eg pyoderma, syphilitic or tuberculous lesions), viral infections (eg chickenpox, herpes simplex, herpes zoster, common wart, flat wart, condyloma, molluscum contagiosum) infections caused by fungi and yeast; parasitic infections (eg scabies) ulcerative skin lesions and wounds; adverse reactions caused by GCS (for example, perioral dermatitis, striae) ichthyosis, juvenile plantar dermatosis, acne vulgaris, rosacea, fragility of skin vessels, skin atrophy; allergic reactions of hypersensitivity to the components of the drug or corticosteroids (the latter rarely occur) skin neoplasms.
Method of administration and dosage:
Apply the drug in a small amount to the skin 1-3 times a day. When the condition improves, as a rule, it is enough to use the drug once a day or 2-3 times a week. The term of application is determined by the doctor. Hydrocortisone should be applied in an even thin layer to the affected skin. The drug can be rubbed gently into the skin to accelerate its penetration. To ensure the best therapeutic effect, an occlusive dressing can be applied.
Application features:
Use with caution in diabetes mellitus. Systemic adverse reactions with topical administration of corticosteroids in adults are extremely rare but can be serious. This is especially true of adrenocortical suppression with prolonged use of the drug.
The risk of systemic effects is increased in the following cases:
  • application using a bandage (cellophane bandage or in the area of skin folds)
  • application on large areas of the skin;
  • long-term treatment;
  • use for children (children are extremely sensitive through thin skin and a relatively large surface area);
  • in the presence of components or excipients, they enhance the penetration through the stratum corneum and / or enhance the effect of the active substance (propylene glycol).

The risk of developing local adverse reactions increases with an increase in the strength of the drug and the duration of treatment. Application with a bandage (cellophane bandage or applied to areas of skin folds) increases this risk.

The skin of the face and scalp, as well as the genitals, is especially sensitive to the occurrence of adverse reactions. If used incorrectly, as well as in the presence of bacterial, parasitic, fungal or viral infections, the manifestations of these diseases can be masked and / or intensified. Do not apply ointment to the eyelids due to the possibility of contact with the conjunctiva and an increased risk of developing common glaucoma or subcapsular cataracts. The drug should be applied with caution to the skin of the face, genitals and scalp, the skin of which is most sensitive to GCS.

The use of the drug in the face, flexors and other areas of thin skin can lead to skin atrophy and increased absorption of the drug. It should be borne in mind that when corticosteroids are used on large areas of the skin, especially with the use of a (cellophane) dressing or in the area of ​​folds, there is a possibility of increased absorption of the drug, which can lead to inhibition of adrenocortical function.

Suppression of the adrenal cortex can develop rapidly in children. Growth hormone production may also be suppressed. If long-term treatment is necessary, it is advisable to regularly monitor the child’s height and weight, as well as determine the levels of cortisol in the blood plasma.

Topical corticosteroids can be hazardous to patients with psoriasis for a number of reasons, including “rebound syndrome” due to the development of tolerance, the risk of generalized pustular psoriasis, or local systemic toxicity due to impaired skin barrier function. Steroids can be used for scalp psoriasis or chronic scaly psoriasis of the hands and feet. It is important to closely monitor the patient. When conducting comparative studies, there were no significant differences in adrenocortical function in children who received Hydrocortisone ointment for 4 weeks.

 

Shelf life:
3 years. Do not use hydrocortisone after the expiry date printed on the package.
Storage conditions:
Store hydrocortisone at a temperature not exceeding 20 ° C.
Produced in Russia